---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-048431"
form_type: "8-K"
ticker: "PTIX"
cik: "0001022899"
company_name: "Protagenic Therapeutics, Inc.new"
filed_at: "2024-12-03T23:59:59+00:00"
generated_at: "2026-05-29T09:24:38.098495+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Protagenic Therapeutics appeals Nasdaq delisting; hearing set for Jan 30, 2025

## Summary
- Nasdaq determined non-compliance with $2.5M stockholders' equity requirement (Rule 5550(b)(1)).
- Company failed to regain compliance by Nov 18, 2024 extension deadline; delisting determination issued Nov 19.
- Appeal filed Nov 27; hearing stayed pending Panel decision; hearing scheduled Jan 30, 2025.
- Materials due Jan 10, 2025; no assurance Panel will grant more time to regain compliance.

## SEC filing metadata
- accession: 0001493152-24-048431
- form_type: 8-K
- ticker: PTIX
- cik: 0001022899
- company_name: Protagenic Therapeutics, Inc.new
- filed_at: 2024-12-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022899/000149315224048431/0001493152-24-048431-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022899/000149315224048431/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-048431
- JSON: https://secwatch.observer/filing/0001493152-24-048431.json
- Plain text: https://secwatch.observer/filing/0001493152-24-048431.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.